In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27,247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study

Author： Bouchillon S.K.   Hoban D.J.   Johnson J.L.   Johnson B.M.   Butler D.L.   Saunders K.A.   Miller L.A.   Poupard J.A.  

Publisher： Elsevier

ISSN： 0924-8579

Source： International Journal of Antimicrobial Agents, Vol.23, Iss.2, 2004-02, pp. : 181-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18&unknown;569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001)

By Jones R.N.   Sader H.S.   Beach M.L.  

International Journal of Antimicrobial Agents, Vol. 22, Iss. 6, 2003-12 ,pp. : 551-556

Elsevier

Access to resources Recommend Favorite

Distinct Dimerization Between -Lactalbumin and Lysozyme Exhibiting Novel Antimicrobial Activity against Gram-positive and Gram-negative Bacteria

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 2, 2004-04 ,pp. : 101-109

Bentham Science Publishers

Access to resources Recommend Favorite

First Study on Antimicriobial Activity and Synergy between Isothiocyanates and Antibiotics Against Selected Gram-Negative And Gram-Positive Pathogenic Bacteria From Clinical And Animal Source

By  

Medicinal Chemistry, Vol. 8, Iss. 3, 2012-05 ,pp. : 474-480

Bentham Science Publishers

Access to resources Recommend Favorite

In vitro Antimicrobial Activity of Liposomes Containing Ciprofloxacin,Meropenem and Gentamicin Against Gram-Negative Clinical Bacterial Strains

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 4, 2007-06 ,pp. : 297-304

Bentham Science Publishers

Access to resources Recommend Favorite

Novel agents for the treatment of resistant Gram-positive infections

By Woodford Neil  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 117-137

Informa Healthcare

Access to resources Recommend Favorite